Approved Ligands

Sildenafil, one of the selective phosphodiesterase-5 (PDE5) inhibitors(IC50= 5.22 nM), is considered the best treatment for erectile dysfunction.A type 5 cGMP phosphodiesterase (PDE5) inhibitor and vasodilator.

Sildenafil, one of the selective phosphodiesterase-5 (PDE5) inhibitors(IC50= 5.22 nM), is considered the best treatment for erectile dysfunction.A type 5 cGMP phosphodiesterase (PDE5) inhibitor and vasodilator.

Sildenafil, one of the selective phosphodiesterase-5 (PDE5) inhibitors(IC50= 5.22 nM), is considered the best treatment for erectile dysfunction.A type 5 cGMP phosphodiesterase (PDE5) inhibitor and vasodilator.

Simeprevir.

Simeprevir.

Simeprevir.

Simeprevir.

Simeprevir.

Simeprevir.

InformationSiponimod (BAF312) BAF312 (Siponimod) is a next-generation S1P receptor agonist, selective for S1P1 and S1P5 receptors with EC50 of 0.39 nM and 0.98 nM, exhibits &gt:1000-fold selectivity over S1P2, S1P3 and S1P4 receptors. Phase

InformationSiponimod (BAF312) BAF312 (Siponimod) is a next-generation S1P receptor agonist, selective for S1P1 and S1P5 receptors with EC50 of 0.39 nM and 0.98 nM, exhibits &gt:1000-fold selectivity over S1P2, S1P3 and S1P4 receptors. Phase

InformationSiponimod (BAF312) BAF312 (Siponimod) is a next-generation S1P receptor agonist, selective for S1P1 and S1P5 receptors with EC50 of 0.39 nM and 0.98 nM, exhibits &gt:1000-fold selectivity over S1P2, S1P3 and S1P4 receptors. Phase